Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous remifentanil infusion vs control for hemodynamic responses to tracheal intubation in elderly patients
ChiCTR2600119376Phase 4Not yet recruiting
- Sponsor
- Meishan Municipal People's Hospital
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil (2 arms), sponsored by Meishan Municipal People's Hospital. Primary endpoint: Maximum rate of change in systolic blood pressure within 5 minutes after endotracheal intubation vs baseline. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2600119376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119376.